Moderna (MRNA) Stock: Slips After Announcing $2 Billion Debt Plan to Fund Growth Strategy

TLDR Moderna stock drops after announcing a $2 billion convertible notes offering plan. The biotech firm targets oncology expansion and debt repayment with new funding. Moderna plans convertible notes with capped calls to reduce potential share dilution. The company expands beyond vaccines while strengthening its financial strategy. MRNA declines as Moderna introduces a new debt [...]

The post Moderna (MRNA) Stock: Slips After Announcing $2 Billion Debt Plan to Fund Growth Strategy appeared first on Blockonomi.